EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
70 hedge funds and large institutions have $230M invested in ESSA Pharma in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.39% less ownership
Funds ownership: 84.89% → 84.5% (-0.39%)
57% less capital invested
Capital invested by funds: $530M → $230M (-$300M)
Holders
70
Holding in Top 10
1
Calls
$146K
Puts
$2K
Top Buyers
| 1 | +$13.6M | |
| 2 | +$7.49M | |
| 3 | +$7.42M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.14M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.46M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$11.4M | |
| 3 | -$10.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.49M |
| 5 |
FM
Frazier Management
Seattle,
Washington
|
-$7.72M |